Depression and anxiety severity scores increased among U.S. adults from August to December 2020, followed by decrease through mid-2021
FDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster Shots
Panel will consider whether third Moderna shot should contain half the original dose, best timing for second shot of single-dose J&J vaccine
FDA Questions Strength of Johnson & Johnson Booster Shot Data
Agency says key test used by the company to measure immune response from booster shot six months after the original shot likely not sensitive enough
COVID-19 Infection Risk Drops With Increasing Immunity Within Family
Risk for COVID-19 infection progressively lower for nonimmune family members as number of family members with immunity increases